Table 2.

Tumor characteristics for patients receiving neoadjuvant therapy prior to surgery.

Characteristic		p-value*
Tumor size, cm		<0.01
Initial (mean ±sd)	(3.7±1.8)
Follow-up (mea n±sd)	(2.7±1.3)
% change	25%
SUV tumor		<0.01
Initial (mean ±sd)	(11.6±4.4)
Follow-up (mean ±sd)	(4.7±2.5)
% change	56%
SUV lymph nodes		<0.01
Initial (mean ±sd)	(6.1±3.5)
Follow-up (mean ±sd)	(2.5±2.2)
% change	51%

^*Based on paired t-test.